[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN108992712A - A kind of cerium oxide nano nerve trachea composition, nerve trachea and its preparation method and application - Google Patents

A kind of cerium oxide nano nerve trachea composition, nerve trachea and its preparation method and application Download PDF

Info

Publication number
CN108992712A
CN108992712A CN201810921128.XA CN201810921128A CN108992712A CN 108992712 A CN108992712 A CN 108992712A CN 201810921128 A CN201810921128 A CN 201810921128A CN 108992712 A CN108992712 A CN 108992712A
Authority
CN
China
Prior art keywords
cerium oxide
nerve
oxide nano
nerve trachea
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810921128.XA
Other languages
Chinese (zh)
Inventor
欧阳元明
袁伟恩
范存义
钱运
赵笑天
程媛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Sixth Peoples Hospital
Original Assignee
Shanghai Sixth Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Sixth Peoples Hospital filed Critical Shanghai Sixth Peoples Hospital
Priority to CN202210207173.5A priority Critical patent/CN114832163A/en
Priority to CN201810921128.XA priority patent/CN108992712A/en
Publication of CN108992712A publication Critical patent/CN108992712A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/025Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/32Materials or treatment for tissue regeneration for nerve reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明提供了一种氧化铈纳米神经导管组合物、神经导管及其制备方法和应用,所述组合物由生物可降解代谢的材料、氧化铈纳米、生物相容粘附材料组成;利用3D打印或静电纺丝生物降解的材料和氧化铈纳米共融或有机溶剂,成型各种生物医学应用的导管,成型后,根据需要在内壁打印或喷涂生物粘附物质层,诱导细胞在导管分化和生长。本发明提供了一种生物学需要的导管支架,具有理想的生物医学功能材料,制备简单、成本低、质量易控制、应用广等优点。大鼠坐骨神经缺损修复实验显示,本发明的氧化铈纳米神经导管促进神经再生,提高再生神经成熟度和发挥作用的神经纤维数,促进坐骨神经功能恢复正常,且效果优于自体神经移植修复,具有很好的应用前景。

The invention provides a cerium oxide nano nerve guide composition, a nerve guide and its preparation method and application, the composition is composed of biodegradable and metabolized materials, cerium oxide nanometers, and biocompatible adhesive materials; using 3D printing Or electrospin biodegradable materials and cerium oxide nanocomposites or organic solvents to form catheters for various biomedical applications. After molding, print or spray a layer of bioadhesive substances on the inner wall according to needs to induce cell differentiation and growth in the catheter . The invention provides a catheter bracket required by biology, which has the advantages of ideal biomedical functional material, simple preparation, low cost, easy quality control, wide application and the like. Rat sciatic nerve defect repair experiments show that the cerium oxide nano-nerve guide of the present invention promotes nerve regeneration, increases the maturity of regenerated nerves and the number of functioning nerve fibers, and promotes the return of sciatic nerve function to normal, and the effect is better than that of autologous nerve transplantation. Good application prospects.

Description

一种氧化铈纳米神经导管组合物、神经导管及其制备方法和 应用A kind of cerium oxide nano nerve guide composition, nerve guide and its preparation method and application

技术领域technical field

本发明涉及生物材料技术领域,具体地说,是一种氧化铈纳米神经导管组合物、神经导管及其制备方法和应用。The invention relates to the technical field of biomaterials, in particular to a cerium oxide nanometer nerve guide composition, a nerve guide and a preparation method and application thereof.

背景技术Background technique

各种生物医用导管,目前包括降解和非降解的导管,如聚乙烯管就曾经被用来做神经导管研究神经再生情况,由于导管的不降解,神经再生完成后,导管如果不处理,可能造成组织纤维化,引起炎症等毒副作用,临床应用效果不是十分理想。目前发展到各种生物可降解材料制备各种生物医用导管,如胶原蛋白、聚乳酸等,但是由于这些材料单独使用也存在一些问题如,强度、神经再生的速度以及毒副作用等缺点。到最近发展到对这些导管进一步研究,如在导管的表面或内部进行各种有利于体内各种腔道损伤的再生,如在导管的表面进行细胞修饰、载各种促进腔道生长的活性物质,如神经导管的神经生长因子、血旺细胞等。Various biomedical catheters currently include degradable and non-degradable catheters. For example, polyethylene tubes have been used as nerve catheters to study nerve regeneration. Due to the non-degradable catheters, after the completion of nerve regeneration, if the catheters are not treated, it may cause Tissue fibrosis causes toxic and side effects such as inflammation, and the clinical application effect is not very satisfactory. At present, various biodegradable materials have been developed to prepare various biomedical catheters, such as collagen, polylactic acid, etc., but because these materials are used alone, there are some problems such as strength, nerve regeneration speed, and toxic side effects. Recently, it has been developed to further research on these catheters, such as performing various regenerations on the surface or inside of the catheter that are beneficial to the regeneration of various lumen injuries in the body, such as performing cell modification on the surface of the catheter, and carrying various active substances that promote the growth of the lumen. , such as nerve growth factor of the nerve conduit, blood cells, etc.

静电纺丝是在盛有聚合物溶液的毛细管施加高压直流电源,在电场的作用下,毛细管末端悬挂的液滴发生变形,形成Taylor锥体,当施加的电场超过某一临界值时,电场力克服溶液的表面张力,形成较细的表面带电的射流,射流在电场的作用下,向接地的收集器运动,在运动过程中,射流不断地拉伸,某些情况射流会发生分裂,分裂成更细的射流,同时溶剂不断挥发,最后在收集器上得到直径为几微米到几十纳米,甚至几纳米的纤维。通过静电纺丝制备的神经导管支架材料不仅可以模拟细胞外基质中的胶原纤维结构,而且具有高孔隙率和比表面积,有利于细胞黏附、生长和增殖。Electrospinning is to apply a high-voltage DC power supply to the capillary containing the polymer solution. Under the action of the electric field, the droplets suspended at the end of the capillary are deformed to form a Taylor cone. When the applied electric field exceeds a certain critical value, the electric field force Overcoming the surface tension of the solution, a finer surface-charged jet is formed. Under the action of the electric field, the jet moves to the grounded collector. During the movement, the jet is continuously stretched, and in some cases the jet will split and split into Finer jets, while the solvent continues to volatilize, and finally fibers with a diameter of several microns to tens of nanometers, or even several nanometers, are obtained on the collector. The nerve conduit scaffold material prepared by electrospinning can not only mimic the collagen fiber structure in the extracellular matrix, but also has high porosity and specific surface area, which is conducive to cell adhesion, growth and proliferation.

神经导管尽管已经取得一定的研究进展,如中国发明专利CN100479785C公开了一种制备神经导管的方法,但是与自体神经修复还存在一定的距离。另外还有多个专利公开了不同的制备方法(如中国发明专利CN101439205A,公开日2009.5.27;CN101507842A,公开日2009.8.19、CN106668938A,公开日2017.05.17;CN106924820A,公开日2017.07.07),但是这些导管要么存在强度、毒副作用、质量控制或成本等问题。现有技术公开的神经导管,都不具有理想的生物医学导管。理想的导管应该具有:具有足够的强度、弹性、硬度等;可降解性且在体内等到所损伤的组织再生完全,而完全降解,不需要再次进行手术取出;材料尽量无毒副作用;合适降解周期;能引导组织朝合适的方向生长;有防止不需要的组织再生等。Although some research progress has been made on nerve guides, for example, the Chinese invention patent CN100479785C discloses a method for preparing nerve guides, but there is still a certain distance from autologous nerve repair. In addition, there are many patents disclosing different preparation methods (such as Chinese invention patent CN101439205A, open date 2009.5.27; CN101507842A, open date 2009.8.19, CN106668938A, open date 2017.05.17; CN106924820A, open date 2017.07.07), But these catheters have issues with either strength, toxicity, quality control, or cost. None of the nerve guides disclosed in the prior art are ideal biomedical guides. An ideal catheter should have: sufficient strength, elasticity, hardness, etc.; degradability and complete degradation in the body until the damaged tissue regenerates completely, and no need to be removed by surgery again; materials should be as non-toxic and side effects as possible; suitable degradation cycle ; It can guide the growth of tissue in the right direction; it can prevent unwanted tissue regeneration, etc.

发明内容Contents of the invention

本发明的第一个目的是针对现有技术中的不足,提供一种氧化铈纳米神经导管。The first purpose of the present invention is to provide a cerium oxide nano nerve guide for the deficiencies in the prior art.

本发明的第二个目的是针对现有技术中的不足,提供一种制备氧化铈纳米神经导管的组合物。The second purpose of the present invention is to provide a composition for preparing cerium oxide nano nerve guides to address the deficiencies in the prior art.

本发明的第三个目的是针对现有技术中的不足,提供如上所述的组合物在制备生物材料中的应用。The third object of the present invention is to provide the application of the above-mentioned composition in the preparation of biological materials to address the deficiencies in the prior art.

本发明的第四个目的是针对现有技术中的不足,提供氧化铈纳米在制备生物材料中的应用。The fourth object of the present invention is to provide the application of cerium oxide nanometers in the preparation of biological materials to address the deficiencies in the prior art.

为实现上述第一个目的,本发明采取的技术方案是:For realizing above-mentioned first object, the technical scheme that the present invention takes is:

一种氧化铈纳米神经导管,所述氧化铈纳米神经导管采用如下方法制备:取生物降解材料重量百分比90-99.5%、氧化铈纳米重量百分比0.5-10%,将生物降解材料用3-6倍重量的有机溶剂溶解,然后加入氧化铈纳米充分混匀,注入注射仪,利用静电纺丝工艺成管,通过直流电压喷射到不断转动的棒状模具上,成管后将神经导管从模具脱下,烘干挥发溶剂,切割成不同长度规格的氧化铈纳米神经导管;所述生物降解材料为聚乳酸、聚乳酸-聚羟基乙酸、聚己内酯、丝蛋白、胶原、明胶、透明质酸、壳聚糖中的一种或多种的组合;所述有机溶剂为二氯甲烷或乙酸乙酯。A cerium oxide nano nerve guide, which is prepared by the following method: take 90-99.5% by weight of biodegradable materials, 0.5-10% by weight of cerium oxide nanometers, and use 3-6 times the weight of biodegradable materials The weight of the organic solvent is dissolved, then the cerium oxide nanometer is added and mixed thoroughly, injected into the injector, and the tube is formed by the electrospinning process, and sprayed onto the continuously rotating rod-shaped mold by direct current voltage. After the tube is formed, the nerve guide is taken off from the mold. Dry the volatile solvent, cut into cerium oxide nano nerve conduits of different lengths and specifications; the biodegradable materials are polylactic acid, polylactic acid-polyglycolic acid, polycaprolactone, silk protein, collagen, gelatin, hyaluronic acid, shell One or more combinations of polysaccharides; the organic solvent is dichloromethane or ethyl acetate.

为实现上述第二个目的,本发明采取的技术方案是:For realizing above-mentioned second purpose, the technical scheme that the present invention takes is:

一种制备氧化铈纳米神经导管的组合物,由生物降解材料和氧化铈纳米组成,重量百分比为:生物降解材料90-99.5%、氧化铈纳米0.5-10%;所述生物降解材料为聚乳酸、聚乳酸-聚羟基乙酸、聚己内酯、丝蛋白、胶原、明胶、透明质酸、壳聚糖中的一种或多种的组合。A composition for preparing a cerium oxide nano nerve guide, which is composed of biodegradable materials and cerium oxide nanometers, and the weight percentage is: 90-99.5% of biodegradable materials, 0.5-10% of cerium oxide nanometers; the biodegradable material is polylactic acid , polylactic acid-polyglycolic acid, polycaprolactone, silk protein, collagen, gelatin, hyaluronic acid, chitosan or a combination of one or more.

在上述制备氧化铈纳米神经导管的组合物中,作为一个优选方案,重量百分比为:生物降解材料95-99%、氧化铈纳米1-5%。In the above composition for preparing cerium oxide nanometer nerve guide, as a preferred solution, the weight percentage is: biodegradable material 95-99%, cerium oxide nanometer 1-5%.

为实现上述第三个目的,本发明采取的技术方案是:For realizing above-mentioned 3rd purpose, the technical scheme that the present invention takes is:

如上任一所述的组合物在制备生物材料中的应用,所述生物材料用于神经损伤后促进外周神经再生。The application of the composition as described above in the preparation of biomaterials for promoting peripheral nerve regeneration after nerve injury.

在上述具体应用中,作为一个优选方案,所述生物材料具体指神经导管。In the above specific application, as a preferred solution, the biological material specifically refers to a nerve guide.

本发明还提供一种氧化铈纳米神经导管,利用上述任一所述的组合物进行3D打印或静电纺丝制备氧化铈纳米神经导管,包括如下步骤:制备生物降解材料和氧化铈纳米混悬液或把氧化铈纳米加入熔融的生物降解材料里混匀得混和物;将上述混悬液或混和物加入到3D打印或静电纺丝设备中,进行打印或静电纺丝制备成所需要的导管。The present invention also provides a cerium oxide nano nerve guide, which is prepared by 3D printing or electrospinning using any of the compositions described above to prepare a cerium oxide nano nerve guide, including the following steps: preparing a biodegradable material and a cerium oxide nanosuspension Or add cerium oxide nanoparticles into the molten biodegradable material and mix to obtain a mixture; add the above suspension or mixture into 3D printing or electrospinning equipment, and print or electrospin to prepare the required catheter.

在上述氧化铈纳米神经导管中,作为一个优选方案,还包括如下步骤:将制备的导管进行内部打印或静电纺丝一层生物粘附物质,并进行交联固化;所述生物粘附物质是指多巴胺、生物粘附肽、细胞外基质中的任意一种或他们任意混合物。In the above-mentioned cerium oxide nano-guide, as a preferred solution, it also includes the following steps: internally print or electrospin a layer of bioadhesive substance on the prepared catheter, and perform cross-linking and curing; the bioadhesive substance is Refers to any one of dopamine, bioadhesive peptides, extracellular matrix or any mixture thereof.

在上述氧化铈纳米神经导管中,作为一个优选方案,所述导管外表面的平均孔径为0.01至10μm,导管内生物粘附层的平均孔径为10-1000μm。In the above-mentioned cerium oxide nano-guide, as a preferred solution, the average pore diameter of the outer surface of the catheter is 0.01 to 10 μm, and the average pore diameter of the bioadhesive layer inside the catheter is 10-1000 μm.

为实现上述第四个目的,本发明采取的技术方案是:For realizing above-mentioned 4th object, the technical scheme that the present invention takes is:

纳米氧化铈在制备生物材料中的应用,所述生物材料用于神经损伤后促进外周神经再生。Application of nano cerium oxide in preparation of biomaterial for promoting peripheral nerve regeneration after nerve injury.

在上述具体应用中,作为一个优选方案,所述生物材料具体指神经导管。In the above specific application, as a preferred solution, the biological material specifically refers to a nerve guide.

本发明优点在于:The present invention has the advantage that:

1、提供了一种具有生物学所需要的导管支架,并有理想的生物医学功能材料。1. Provide a catheter stent that meets biological needs and has ideal biomedical functional materials.

2、具有足够的强度、弹性、硬度、可降解性,移植后在体内等所损伤的组织再生完全,神经导管完全降解,不需要再次进行手术取出;2. It has sufficient strength, elasticity, hardness, and degradability, and the damaged tissue in the body after transplantation is completely regenerated, and the nerve guide is completely degraded, and no further surgery is required to remove it;

3、大鼠坐骨神经缺损修复实验显示,本发明的氧化铈纳米神经导管可促进神经再生,提高再生神经成熟度和发挥作用的神经纤维数,提高大鼠坐骨神经功能指数,促进坐骨神经功能恢复正常,且效果优于自体神经移植修复,具有很好的应用前景。3. The rat sciatic nerve defect repair experiment shows that the cerium oxide nano-nerve guide of the present invention can promote nerve regeneration, improve the maturity of the regenerative nerve and the number of nerve fibers that play a role, improve the rat sciatic nerve function index, and promote the return of sciatic nerve function to normal, and The effect is better than that of autologous nerve transplantation, and it has a good application prospect.

附图说明Description of drawings

附图1为本发明实施例制备的神经导管形貌图。Accompanying drawing 1 is the appearance diagram of the nerve guide prepared by the embodiment of the present invention.

附图2为纯PLA导管再生神经透射电镜检测结果图。Accompanying drawing 2 is the graph of transmission electron microscope detection result of pure PLA catheter regenerative nerve.

附图3为自体神经移植的再生神经透射电镜检测结果图。Accompanying drawing 3 is the transmission electron microscope detection result diagram of the regenerated nerve of autologous nerve transplantation.

附图4为本发明实施例制备的1%的氧化铈纳米和PCL组合物制备神经导管组再生神经透射电镜检测结果图。Accompanying drawing 4 is the transmission electron microscope detection result of nerve conduit group regeneration nerve prepared by 1% cerium oxide nanometer and PCL composition prepared in the embodiment of the present invention.

具体实施方式Detailed ways

下面结合具体实施方式,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明记载的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。The present invention will be further described below in combination with specific embodiments. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the contents of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.

实施例1神经导管生物降解材料组合物Embodiment 1 nerve guide biodegradable material composition

取聚乳酸重量比99%,氧化铈纳米(10-1000nm)重量比1%,将聚乳酸用3-6倍重量的二氯甲烷溶解,然后加入氧化铈纳米充分混匀,制备神经导管生物降解材料组合物。The weight ratio of polylactic acid is 99%, the weight ratio of cerium oxide nanometer (10-1000nm) is 1%, the polylactic acid is dissolved with 3-6 times the weight of methylene chloride, and then the cerium oxide nanometer is added and mixed well to prepare the biodegradable nerve guide material composition.

实施例2神经导管生物降解材料组合物Embodiment 2 nerve guide biodegradable material composition

取聚乳酸-聚羟基乙酸重量比99.5%,氧化铈纳米重量比0.5%,将聚乳酸-聚羟基乙酸用3-6倍重量的乙酸乙酯溶解,然后加入氧化铈纳米充分混匀,制备神经导管生物降解材料组合物。The weight ratio of polylactic acid-polyglycolic acid is 99.5%, and the weight ratio of cerium oxide nanometer is 0.5%. Dissolve polylactic acid-polyglycolic acid with 3-6 times the weight of ethyl acetate, then add cerium oxide nanometer and mix well to prepare nerve Catheter biodegradable material composition.

实施例3神经导管生物降解材料组合物Embodiment 3 nerve guide biodegradable material composition

取聚己内酯重量比98%,氧化铈纳米重量比2%,将聚己内酯用3-6倍重量的二氯甲烷溶解,然后加入氧化铈纳米充分混匀,制备神经导管生物降解材料组合物。The weight ratio of polycaprolactone is 98%, the weight ratio of cerium oxide nanometer is 2%, the polycaprolactone is dissolved with 3-6 times the weight of methylene chloride, and then the cerium oxide nanometer is added to mix well to prepare the nerve guide biodegradable material combination.

实施例4神经导管生物降解材料组合物Embodiment 4 nerve guide biodegradable material composition

取聚乳酸重量比95%,氧化铈纳米重量比5%,将氧化铈纳米加入到熔融的聚乳酸中充分混匀,制备神经导管生物降解材料组合物。The weight ratio of the polylactic acid is 95%, and the weight ratio of the cerium oxide nanometer is 5%, and the cerium oxide nanometer is added into the melted polylactic acid and mixed thoroughly to prepare a nerve guide biodegradable material composition.

实施例5神经导管生物降解材料组合物Embodiment 5 nerve guide biodegradable material composition

取聚乳酸-聚羟基乙酸重量比90%,氧化铈纳米重量比10%,将氧化铈纳米加入到熔融的聚乳酸-聚羟基乙酸中充分混匀,制备神经导管生物降解材料组合物。The weight ratio of polylactic acid-polyglycolic acid is 90%, and the weight ratio of cerium oxide nanometer is 10%, and the cerium oxide nanometer is added to the molten polylactic acid-polyglycolic acid and mixed well to prepare the nerve guide biodegradable material composition.

实施例6神经导管的制备The preparation of embodiment 6 nerve guide

取实施例1-5任一所述的生物降解材料组合物制备导管,采用常规的静电纺丝技术制备各种需要的导管;或者采用3D打印技术,打印各种导管;或者采用导管模具制备各种所需要的导管。如3D打印的和1%的氧化铈纳米PCL神经导管具有良好神经再生性能如弹性模量比纯PCL打印要好(分别是48.32和31.77MPa)等。Take the biodegradable material composition described in any one of Examples 1-5 to prepare catheters, and use conventional electrospinning technology to prepare various required catheters; or use 3D printing technology to print various catheters; or use catheter molds to prepare various catheters. the required catheter. For example, 3D printed and 1% cerium oxide nano-PCL nerve guides have good nerve regeneration properties, such as elastic modulus better than pure PCL printing (48.32 and 31.77 MPa, respectively).

实施例7神经导管的制备The preparation of embodiment 7 nerve guide

在实施例6的神经导管基础上,进行内部打印或静电纺丝一层生物粘附物质,并进行交联固化。生物粘附物质可以是多巴胺、生物粘附肽或细胞外基质中的任意一种,或他们任意比例混合。On the basis of the nerve guide in Example 6, a layer of bioadhesive substance is internally printed or electrospun, and then cross-linked and cured. The bioadhesive substance can be any one of dopamine, bioadhesive peptide or extracellular matrix, or a mixture of them in any proportion.

实施例8神经导管的制备The preparation of embodiment 8 nerve guide

利用实施例1的生物降解材料组合物制备导管,具体步骤如下:取神经导管生物降解材料组合物,除泡后取100ml注入注射仪中以流量15ml/h的速度输出,使用静电纺丝工艺成管,通过直流电压喷射到转速为600rpm、直径为3mm的棒状模具上,电压20KV,接收距离20cm。静电纺丝喷头在水平方向上以10cm/min速度往返运动,成管长度15-20cm。溶液喷射完后棒状模具继续旋转5-10h,使溶剂挥发。将神经导管从模具脱下,烘干完全挥发溶剂,将神经导管切成不同长度规格。Utilize the biodegradable material composition of Example 1 to prepare the catheter, the specific steps are as follows: take the nerve catheter biodegradable material composition, take 100ml after defoaming, inject it into the injector and output it at a flow rate of 15ml/h, and use the electrospinning process to form the catheter. The tube is sprayed onto a rod-shaped mold with a rotating speed of 600rpm and a diameter of 3mm through a DC voltage, a voltage of 20KV, and a receiving distance of 20cm. The electrospinning nozzle moves back and forth at a speed of 10cm/min in the horizontal direction, and the length of the tube is 15-20cm. After the solution is sprayed, the rod-shaped mold continues to rotate for 5-10 hours to evaporate the solvent. The nerve guide is taken off from the mold, dried to completely evaporate the solvent, and the nerve guide is cut into different length specifications.

实施例9神经导管的制备The preparation of embodiment 9 nerve guide

利用实施例1的生物降解材料组合物制备导管,具体步骤如下:取聚乳酸重量比99%,多巴胺重量比1%,将聚乳酸用3-6倍重量的二氯甲烷溶解,然后加入多巴胺充分混匀,得混合物。将混合物除泡后取10ml注入注射仪中以流量10ml/h的速度输出,使用静电纺丝工艺成管,通过直流电压喷射到转速为800rpm、直径为3mm的棒状模具上,电压20KV,接收距离20cm。静电纺丝喷头在水平方向上以15cm/min速度往返运动,成管长度15-20cm。溶液喷射完后棒状模具继续旋转5-10h,使溶剂挥发。取神经导管生物降解材料组合物,除泡后取100ml注入注射仪中以流量10ml/h的速度输出,使用静电纺丝工艺成管,通过直流电压喷射到转速为800rpm棒状模具管体表面,电压20KV,接收距离20cm。静电纺丝喷头在水平方向上以15cm/min速度往返运动,成管长度15-20cm。将神经导管从模具脱下,烘干完全挥发溶剂,将神经导管切成不同长度规格。Utilize the biodegradable material composition of embodiment 1 to prepare catheter, concrete steps are as follows: take polylactic acid weight ratio 99%, dopamine weight ratio 1%, polylactic acid is dissolved with the dichloromethane of 3-6 times weight, then add dopamine fully Mix well to obtain a mixture. Take 10ml of the mixture after defoaming and inject it into the injector at a flow rate of 10ml/h, and use the electrospinning process to form a tube, and spray it onto a rod-shaped mold with a rotation speed of 800rpm and a diameter of 3mm through a DC voltage, the voltage is 20KV, and the receiving distance 20cm. The electrospinning nozzle moves back and forth at a speed of 15cm/min in the horizontal direction, and the length of the tube is 15-20cm. After the solution is sprayed, the rod-shaped mold continues to rotate for 5-10 hours to evaporate the solvent. Take the nerve conduit biodegradable material composition, after defoaming, take 100ml and inject it into the injection device at a flow rate of 10ml/h, and use the electrospinning process to form a tube, and spray it on the surface of the tube body of the rod-shaped mold with a rotation speed of 800rpm through a DC voltage. 20KV, the receiving distance is 20cm. The electrospinning nozzle moves back and forth at a speed of 15cm/min in the horizontal direction, and the length of the tube is 15-20cm. The nerve guide is taken off from the mold, dried to completely evaporate the solvent, and the nerve guide is cut into different length specifications.

实施例10神经导管的制备The preparation of embodiment 10 nerve guide

利用实施例2的生物降解材料组合物制备导管,具体步骤如下:取神经导管生物降解材料组合物除泡后取100ml注入注射仪中以流量10ml/h的速度输出,使用静电纺丝工艺成管,通过直流电压喷射到转速为900rpm、直径为5mm的棒状模具上,电压20KV,接收距离20cm。静电纺丝喷头在水平方向上以15cm/min速度往返运动,成管长度15-20cm。溶液喷射完后棒状模具继续旋转,使溶剂挥发。将神经导管从模具脱下,烘干完全挥发溶剂,将神经导管切成不同长度规格。Utilize the biodegradable material composition of Example 2 to prepare the catheter, the specific steps are as follows: take 100ml of the nerve catheter biodegradable material composition after defoaming, inject it into the injector and output it at a flow rate of 10ml/h, and use the electrospinning process to form a catheter , sprayed onto a rod-shaped mold with a rotational speed of 900rpm and a diameter of 5mm through a DC voltage, a voltage of 20KV, and a receiving distance of 20cm. The electrospinning nozzle moves back and forth at a speed of 15cm/min in the horizontal direction, and the length of the tube is 15-20cm. After the solution is sprayed, the rod mold continues to rotate to evaporate the solvent. The nerve guide is taken off from the mold, dried to completely evaporate the solvent, and the nerve guide is cut into different length specifications.

实施例11神经导管的制备The preparation of embodiment 11 nerve guide

利用实施例2的生物降解材料组合物制备导管,具体步骤如下:取聚乳酸-聚羟基乙酸重量比99.5%,生物粘附肽重量比0.5%,将聚乳酸-聚羟基乙酸用3-6倍重量的乙酸乙酯溶解,然后加入生物粘附肽充分混匀,得混合物。将混合物除泡后取10ml注入注射仪中以流量10ml/h的速度输出,使用静电纺丝工艺成管,通过直流电压喷射到转速为1000rpm、直径为5mm的棒状模具上,电压20KV,接收距离20cm。静电纺丝喷头在水平方向上以10cm/min速度往返运动,成管长度15-20cm。溶液喷射完后棒状模具继续旋转,使溶剂挥发。取神经导管生物降解材料组合物,除泡后取100ml注入注射仪中以流量5ml/h的速度输出,使用静电纺丝工艺成管,通过直流电压喷射到转速为1000rpm棒状模具管体表面,电压20KV,接收距离20cm。静电纺丝喷头在水平方向上以10cm/min速度往返运动,成管长度15-20cm。溶液喷射完后棒状模具继续旋转,使溶剂挥发。将神经导管从模具脱下,烘干完全挥发溶剂,将神经导管切成不同长度规格。Utilize the biodegradable material composition of embodiment 2 to prepare catheter, specific steps are as follows: take polylactic acid-polyglycolic acid weight ratio 99.5%, bioadhesive peptide weight ratio 0.5%, polylactic acid-polyglycolic acid is used 3-6 times Weight of ethyl acetate was dissolved, and then the bioadhesive peptide was added and mixed thoroughly to obtain a mixture. Take 10ml of the mixture after defoaming and inject it into the injector at a flow rate of 10ml/h, and use the electrospinning process to form a tube, and spray it on a rod-shaped mold with a rotation speed of 1000rpm and a diameter of 5mm through a DC voltage, the voltage is 20KV, and the receiving distance 20cm. The electrospinning nozzle moves back and forth at a speed of 10cm/min in the horizontal direction, and the length of the tube is 15-20cm. After the solution is sprayed, the rod mold continues to rotate to evaporate the solvent. Take the nerve conduit biodegradable material composition, after defoaming, take 100ml and inject it into the injection device at a flow rate of 5ml/h, and use the electrospinning process to form a tube, and spray it on the surface of the tube body of the rod-shaped mold with a rotation speed of 1000rpm through a DC voltage. 20KV, the receiving distance is 20cm. The electrospinning nozzle moves back and forth at a speed of 10cm/min in the horizontal direction, and the length of the tube is 15-20cm. After the solution is sprayed, the rod mold continues to rotate to evaporate the solvent. The nerve guide is taken off from the mold, dried to completely evaporate the solvent, and the nerve guide is cut into different length specifications.

实施例12神经导管的制备The preparation of embodiment 12 nerve guide

利用实施例3的生物降解材料组合物制备导管,具体步骤如下:取神经导管生物降解材料组合物,除泡后取100ml注入注射仪中以流量15ml/h的速度输出,使用静电纺丝工艺成管,通过直流电压喷射到转速为1000rpm、直径为5mm的棒状模具上,电压20KV,接收距离20cm。静电纺丝喷头在水平方向上以15cm/min速度往返运动,成管长度15-20cm。溶液喷射完后棒状模具继续旋转,使溶剂挥发。将神经导管从模具脱下,烘干完全挥发溶剂,将神经导管切成不同长度规格。Utilize the biodegradable material composition of Example 3 to prepare the catheter, the specific steps are as follows: take the nerve catheter biodegradable material composition, take 100ml after defoaming and inject it into the injector at a flow rate of 15ml/h, and use the electrospinning process to form the catheter. The tube is sprayed onto a rod-shaped mold with a rotational speed of 1000rpm and a diameter of 5mm through a DC voltage, a voltage of 20KV, and a receiving distance of 20cm. The electrospinning nozzle moves back and forth at a speed of 15cm/min in the horizontal direction, and the length of the tube is 15-20cm. After the solution is sprayed, the rod mold continues to rotate to evaporate the solvent. The nerve guide is taken off from the mold, dried to completely evaporate the solvent, and the nerve guide is cut into different length specifications.

实施例13神经导管的制备The preparation of embodiment 13 nerve guide

利用实施例3的生物降解材料组合物制备导管,具体步骤如下:取聚己内酯重量比98%,多巴胺重量比2%,将聚己内酯用3-6倍重量的二氯甲烷溶解,然后加入多巴胺充分混匀,得混合物。取混合物除泡后取10ml注入注射仪中以流量15ml/h的速度输出,使用静电纺丝工艺成管,通过直流电压喷射到转速为1000rpm、直径为5mm的棒状模具上,电压20KV,接收距离20cm。静电纺丝喷头在水平方向上以15cm/min速度往返运动,成管长度15-20cm。溶液喷射完后棒状模具继续旋转,使溶剂挥发。取神经导管生物降解材料组合物,除泡后取100ml注入注射仪中以流量15ml/h的速度输出,使用静电纺丝工艺成管,通过直流电压喷射到转速为1000rpm棒状模具管体表面,电压20KV,接收距离20cm。静电纺丝喷头在水平方向上以15cm/min速度往返运动,成管长度15-20cm。溶液喷射完后棒状模具继续旋转,使溶剂挥发。将神经导管从模具脱下,烘干完全挥发溶剂,将神经导管切成不同长度规格。Utilizing the biodegradable material composition of Example 3 to prepare a catheter, the specific steps are as follows: take polycaprolactone with a weight ratio of 98%, and dopamine with a weight ratio of 2%, and dissolve polycaprolactone with 3-6 times the weight of dichloromethane, Then add dopamine and mix thoroughly to obtain a mixture. After defoaming the mixture, take 10ml and inject it into the injector at a flow rate of 15ml/h, and use the electrospinning process to form a tube, and spray it on a rod-shaped mold with a rotation speed of 1000rpm and a diameter of 5mm through a DC voltage, the voltage is 20KV, and the receiving distance 20cm. The electrospinning nozzle moves back and forth at a speed of 15cm/min in the horizontal direction, and the length of the tube is 15-20cm. After the solution is sprayed, the rod mold continues to rotate to evaporate the solvent. Take the nerve conduit biodegradable material composition, after defoaming, take 100ml and inject it into the injector at a flow rate of 15ml/h, and use the electrospinning process to form a tube, and spray it on the surface of the tube body of the rod-shaped mold with a rotation speed of 1000rpm through a DC voltage. 20KV, the receiving distance is 20cm. The electrospinning nozzle moves back and forth at a speed of 15cm/min in the horizontal direction, and the length of the tube is 15-20cm. After the solution is sprayed, the rod mold continues to rotate to evaporate the solvent. The nerve guide is taken off from the mold, dried to completely evaporate the solvent, and the nerve guide is cut into different length specifications.

实施例14动物实验Embodiment 14 Animal experiments

将上述实施例8制备的神经导管植入大鼠的坐骨神经(修复15MM的损伤),如图1所示选取1%氧化铈纳米的PCL材料的导管。如图2-4所示,髓鞘厚度是反映再生神经成熟的重要指标,图中结果显示,在术后第12周,1%的氧化铈纳米和PCL组合物制备神经导管髓鞘厚度大于纯PLA导管组和自体神经移植组,表明本发明的神经导管具有显著的促进神经再生作用,效果优于自体神经和纯PCL导管。The nerve guide prepared in the above-mentioned Example 8 was implanted into the sciatic nerve of the rat (to repair the damage of 15 mm), and the guide tube made of 1% cerium oxide nanometer PCL material was selected as shown in FIG. 1 . As shown in Figures 2-4, the thickness of myelin sheath is an important indicator reflecting the maturation of regenerative nerves. The results in the figure show that at the 12th week after operation, the thickness of myelin sheath of the nerve conduit prepared by 1% cerium oxide nanometer and PCL composition is greater than that of pure The PLA conduit group and the autologous nerve transplantation group show that the nerve conduit of the present invention has a remarkable effect of promoting nerve regeneration, and the effect is better than that of the autologous nerve and pure PCL conduit.

实施例15动物实验Embodiment 15 Animal experiments

健康成年雄性SD大鼠30只,按照随机数字表法分为A、B两组,每组15只。所有大鼠右侧为实验侧,左侧为正常对照侧。氯胺酮腹腔注射麻醉下,大鼠右股后外侧行纵形切口,自肌间隙进入显露坐骨神经。于大腿中段切取坐骨神经干10mm,A组用自体神经行原位神经移植;B组用实施例9制备的神经导管桥接修复,两神经断端各插入导管内1mm,保留神经缺损10mm间隙,以9-0丝线缝合管壁与神经外膜,每端3-4针。术后分笼饲养。第4、6、8、10周检测各组大鼠坐骨神经功能指数(SFI)值,SFI在接近0表示坐骨神经功能正常,当SFI值在-100表示坐骨神经功能完全丧失。按照SFI公式进行计算:SFI=-38.3(EPL-NPL)/NPL+109.5(ETS–NTS)/NTS+13.3(EIT-NIT)/NIT-8.8(E:Experimental试验侧足;N:Normal正常侧足)。结果如下表所示。术后第二周,两组SFI值比较无显著性差异(P>0.05),从第8周开始,两组SFI值显示显著性差异,B组SFI值与A组比较显著提高,表明本发明的神经导管可显著促进坐骨神经功能恢复正常。Thirty healthy adult male SD rats were divided into two groups A and B according to the random number table method, with 15 rats in each group. The right side of all rats is the experimental side, and the left side is the normal control side. Under anesthesia by intraperitoneal injection of ketamine, a longitudinal incision was made on the posterolateral aspect of the right femur, and the sciatic nerve was exposed from the intermuscular space. A 10 mm trunk of the sciatic nerve was excised from the middle part of the thigh, and group A used autologous nerves for in situ nerve transplantation; group B used the nerve conduit prepared in Example 9 to bridge and repair, and the two nerve stumps were respectively inserted into the conduit 1 mm, and a gap of 10 mm was reserved for the nerve defect. -0 silk sutures the wall and the epineurium with 3-4 stitches at each end. After operation, they were housed in separate cages. The sciatic nerve function index (SFI) values of the rats in each group were detected at the 4th, 6th, 8th, and 10th weeks. When the SFI was close to 0, it indicated that the sciatic nerve function was normal. When the SFI value was -100, it indicated that the sciatic nerve function was completely lost. Calculated according to the SFI formula: SFI=-38.3(EPL-NPL)/NPL+109.5(ETS–NTS)/NTS+13.3(EIT-NIT)/NIT-8.8 (E: Experimental side foot; N: Normal side foot). The results are shown in the table below. In the second week after the operation, the SFI values of the two groups had no significant difference (P>0.05). From the 8th week, the SFI values of the two groups showed significant differences. The nerve guide can significantly promote the normal function of the sciatic nerve.

表1术后两组坐骨神经功能指数SFI比较Table 1 Comparison of sciatic nerve functional index SFI between the two groups after operation

术后时间postoperative time A组Group A B组Group B 2周Two weeks -87±2.90-87±2.90 -86±2.75-86±2.75 4周4 weeks -74±2.65-74±2.65 -71±2.55-71±2.55 6周6 weeks -65±2.40-65±2.40 -58±2.45-58±2.45 8周8 weeks -51±2.35-51±2.35 -42±2.30-42±2.30 10周10 weeks -48±2.25-48±2.25 -33±2.15-33±2.15

第12周于坐骨神经远端吻合口2mm处切取再生神经,用4%戊二醛固定,1%锇酸固定,包埋,切片,染色,在透射电镜下观察截面左上、左下、正中、右上、右下五处单位视野,统计髓神经纤维数,测量轴突直径和髓鞘厚度。结果如下表所示。轴突直径和髓鞘厚度是神经成熟的主要形态学标志,再生神经内有较成熟的髓神经纤维为有效再生。从表中的结果可以看出,B组在再生神经纤维数、轴突直径和髓鞘厚度方面显著高于A组,表明本发明的神经导管可促进神经再生,提高再生神经成熟度和发挥作用的神经纤维数。At the 12th week, regenerated nerves were cut at 2 mm from the anastomosis at the distal end of the sciatic nerve, fixed with 4% glutaraldehyde and 1% osmic acid, embedded, sectioned, and stained. In the lower right five unit fields of view, the number of myelinated nerve fibers was counted, and the diameter of the axon and the thickness of the myelin sheath were measured. The results are shown in the table below. Axon diameter and myelin sheath thickness are the main morphological markers of nerve maturation, and more mature myelinated nerve fibers in regenerated nerves are effective regeneration. As can be seen from the results in the table, group B is significantly higher than group A in the number of regenerated nerve fibers, axon diameter and myelin sheath thickness, indicating that the nerve guide of the present invention can promote nerve regeneration, improve the maturity of regenerated nerves and play a role number of nerve fibers.

表2术后12周两组再生神经纤维数、轴突直径和髓鞘厚度比较Table 2 Comparison of the number of regenerated nerve fibers, axon diameter and myelin sheath thickness between the two groups at 12 weeks after operation

神经纤维数number of nerve fibers 轴突直径(μm)Axon diameter (μm) 髓鞘厚度(μm)Myelin thickness (μm) A组Group A 225.1±13.5225.1±13.5 3.61±0.643.61±0.64 1.21±0.081.21±0.08 B组Group B 245.1±15.8* 245.1±15.8 * 4.41±0.82* 4.41±0.82 * 1.42±0.12* 1.42±0.12 *

注:*表示与A组比较,P<0.05。Note: * means compared with group A, P<0.05.

以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员,在不脱离本发明方法的前提下,还可以做出若干改进和补充,这些改进和补充也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention, it should be pointed out that for those of ordinary skill in the art, without departing from the method of the present invention, some improvements and supplements can also be made, and these improvements and supplements should also be considered Be the protection scope of the present invention.

Claims (10)

1. a kind of cerium oxide nano nerve trachea, which is characterized in that the cerium oxide nano nerve trachea is made with the following method It is standby: biodegradation material weight percent 90-99.5%, cerium oxide nano weight percent 0.5-10% are taken, it will be biodegradable The organic solvent of 3-6 times of weight of material dissolves, and cerium oxide nano is then added and mixes well, injects injection instrument, utilizes electrostatic Spinning technique is ejected on the bar molds constantly rotated at pipe by DC voltage, and Cheng Guanhou takes off nerve trachea from mold Under, solvent flashing is dried, the cerium oxide nano nerve trachea of different length specification is cut into;The biodegradation material is poly- cream One of acid, polyglycolic-polylactic acid, polycaprolactone, silk-fibroin, collagen, gelatin, hyaluronic acid, chitosan are a variety of Combination;The organic solvent is methylene chloride or ethyl acetate.
2. a kind of composition for preparing cerium oxide nano nerve trachea, which is characterized in that received by biodegradation material and cerium oxide Meter Zu Cheng, weight percent are as follows: biodegradation material 90-99.5%, cerium oxide nano 0.5-10%;The biodegradation material For one of polylactic acid, polyglycolic-polylactic acid, polycaprolactone, silk-fibroin, collagen, gelatin, hyaluronic acid, chitosan Or a variety of combination.
3. composition according to claim 2, which is characterized in that weight percent are as follows: biodegradation material 95-99%, Cerium oxide nano 1-5%.
4. any composition of claim 2-3 is preparing the application in biomaterial, the biomaterial is for nerve Promote peripheral nerve regeneration after damage.
5. application according to claim 4, which is characterized in that the biomaterial refers specifically to nerve trachea.
6. a kind of cerium oxide nano nerve trachea, which is characterized in that carried out using the composition any in claim 2-3 3D printing or electrostatic spinning prepare cerium oxide nano nerve trachea, include the following steps: to prepare biodegradation material and cerium oxide Nanosuspension or cerium oxide nano be added melting biodegradation material in mix to obtain mixture;By above-mentioned suspension or mix It is added in 3D printing or electrospinning device with object, carries out printing or electrostatic spinning is prepared into required conduit.
7. cerium oxide nano nerve trachea according to claim 6, which is characterized in that further include following steps: will prepare Conduit carry out one layer of bioadhesion substance of house print or electrostatic spinning, and carry out crosslinking curing;The bioadhesion substance Refer to dopamine, bioadhesion peptide, any one or their any mixtures in extracellular matrix.
8. cerium oxide nano nerve trachea according to claim 7, which is characterized in that the average hole of the catheter outer surface Diameter is 0.01 to 10 μm, and the average pore size of bioadhesive layer is 10-1000 μm in conduit.
9. nano-cerium oxide is preparing the application in biomaterial, which is characterized in that after the biomaterial is used for neurotrosis Promote peripheral nerve regeneration.
10. application according to claim 9, which is characterized in that the biomaterial refers specifically to nerve trachea.
CN201810921128.XA 2018-08-14 2018-08-14 A kind of cerium oxide nano nerve trachea composition, nerve trachea and its preparation method and application Pending CN108992712A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202210207173.5A CN114832163A (en) 2018-08-14 2018-08-14 Cerium oxide nano nerve conduit and preparation method thereof
CN201810921128.XA CN108992712A (en) 2018-08-14 2018-08-14 A kind of cerium oxide nano nerve trachea composition, nerve trachea and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810921128.XA CN108992712A (en) 2018-08-14 2018-08-14 A kind of cerium oxide nano nerve trachea composition, nerve trachea and its preparation method and application

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202210207173.5A Division CN114832163A (en) 2018-08-14 2018-08-14 Cerium oxide nano nerve conduit and preparation method thereof

Publications (1)

Publication Number Publication Date
CN108992712A true CN108992712A (en) 2018-12-14

Family

ID=64596687

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202210207173.5A Pending CN114832163A (en) 2018-08-14 2018-08-14 Cerium oxide nano nerve conduit and preparation method thereof
CN201810921128.XA Pending CN108992712A (en) 2018-08-14 2018-08-14 A kind of cerium oxide nano nerve trachea composition, nerve trachea and its preparation method and application

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN202210207173.5A Pending CN114832163A (en) 2018-08-14 2018-08-14 Cerium oxide nano nerve conduit and preparation method thereof

Country Status (1)

Country Link
CN (2) CN114832163A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109793594A (en) * 2019-02-18 2019-05-24 北京科技大学 Block structure conductive nerve conduit capable of spontaneous electrical stimulation and preparation method thereof
CN113827772A (en) * 2020-06-23 2021-12-24 中国科学院上海硅酸盐研究所 Biological antioxidant nano coating with redox response drug release function and preparation method and application thereof
CN115282332A (en) * 2022-01-10 2022-11-04 上海市第六人民医院 Cerium oxide loaded nano enzyme bionic scaffold and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102285678A (en) * 2011-06-09 2011-12-21 北京大学 Method for preparing cerium oxide nano particles and antioxidation use thereof
IE20100460A1 (en) * 2010-07-22 2012-03-28 Cork Inst Technology A biomaterial to assist growth of a tissue
CN104667351A (en) * 2015-03-09 2015-06-03 盐城工业职业技术学院 Nerve growth factor loaded silk fibroin nanofiber scaffold and preparation method
CN107912023A (en) * 2015-04-15 2018-04-13 牛津大学创新有限公司 embolic particles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101507842A (en) * 2009-03-20 2009-08-19 东华大学 Preparation method of helical flexible pressure-resistance nerve conduit

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE20100460A1 (en) * 2010-07-22 2012-03-28 Cork Inst Technology A biomaterial to assist growth of a tissue
CN102285678A (en) * 2011-06-09 2011-12-21 北京大学 Method for preparing cerium oxide nano particles and antioxidation use thereof
CN104667351A (en) * 2015-03-09 2015-06-03 盐城工业职业技术学院 Nerve growth factor loaded silk fibroin nanofiber scaffold and preparation method
CN107912023A (en) * 2015-04-15 2018-04-13 牛津大学创新有限公司 embolic particles

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
朱家恺等: "《现代周围神经科学 第1版》", 31 October 2007, 上海科学技术出版社 *
王正国: "《创伤学·基础与临床 下》", 31 October 2006, 湖北科学技术出版社 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109793594A (en) * 2019-02-18 2019-05-24 北京科技大学 Block structure conductive nerve conduit capable of spontaneous electrical stimulation and preparation method thereof
CN113827772A (en) * 2020-06-23 2021-12-24 中国科学院上海硅酸盐研究所 Biological antioxidant nano coating with redox response drug release function and preparation method and application thereof
CN113827772B (en) * 2020-06-23 2022-08-09 中国科学院上海硅酸盐研究所 Biological antioxidant nano coating with redox response drug release function and preparation method and application thereof
CN115282332A (en) * 2022-01-10 2022-11-04 上海市第六人民医院 Cerium oxide loaded nano enzyme bionic scaffold and preparation method thereof

Also Published As

Publication number Publication date
CN114832163A (en) 2022-08-02

Similar Documents

Publication Publication Date Title
CN101230150B (en) Method for preparing pure sodium alginate nano fiber membrane material
US8263187B2 (en) Composite of support matrix and collagen, and method for production of support matrix and composite
KR101182736B1 (en) Core-shell type nano fibrous Scaffolds and manufacturing method thereof
CN110651074A (en) Nanofibers comprising fibroin and systems comprising hydrogel and said nanofibers
CN108992712A (en) A kind of cerium oxide nano nerve trachea composition, nerve trachea and its preparation method and application
CN109758617B (en) Nerve repair membrane and preparation method and application thereof
CN114796628B (en) A kind of melatonin nerve conduit and preparation method thereof
de Lima et al. Electrospinning of hydrogels for biomedical applications
WO2020062976A1 (en) Degradable surgical suture with biological activity and preparation method therefor
KR101816286B1 (en) A Multi-Layered Tube-type Porous Scaffold Comprising Biodegradable Polymer And Manufacturing Method Thereof
Joshi et al. Electrospun nano-architectures for tissue engineering and regenerative medicine
CN103263381B (en) Fiber type controllable drug sustained release system and preparation method thereof
JP4383763B2 (en) Cell culture substrate and method for producing the same
US20180002835A1 (en) Composite fibers and matrices thereof
CN103893817B (en) A kind of coaxial electrostatic spinning fibrous framework and preparation method thereof
KR20150053371A (en) Bone graft material for regeneration of periodontal tissue and preparation method thereof
Suwantong et al. Electrospun zein fibrous membranes using glyoxal as cross-linking agent: preparation, characterization and potential for use in biomedical applications
JP2023009090A (en) Method for manufacturing porous anti-adhesive film
CN108379655B (en) Nerve graft with three-dimensional orientation structure and preparation method and manufacturing equipment thereof
Owidaa et al. Biomimetic tissue regeneration using electrospun nanofibrous scaffolds
TW200423976A (en) Anti-adhesive membrane and method for production thereof
Pramanik et al. Electrospun nanofibrous scaffolds for neural tissue engineering
CN111407922A (en) Black phosphorus composition, biological material containing black phosphorus composition, preparation method and application
KR101547603B1 (en) Composition for electrospinning and application thereof
CN109833520A (en) A kind of zinc oxide catheter combination object, conduit preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination